A multiple-center phase II study of weekly docetaxel and oxaliplatin as first-line treatment in patients with advanced gastric cancer. [electronic resource]
Producer: 20120530Description: 49-55 p. digitalISSN:- 1436-3305
- Adenocarcinoma -- drug therapy
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Disease Progression
- Docetaxel
- Female
- Humans
- Male
- Middle Aged
- Neoplasm Staging
- Organoplatinum Compounds -- administration & dosage
- Oxaliplatin
- Stomach Neoplasms -- drug therapy
- Survival Rate
- Taxoids -- administration & dosage
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study
There are no comments on this title.
Log in to your account to post a comment.